{"id":6364,"date":"2022-09-01T15:03:00","date_gmt":"2022-09-01T10:03:00","guid":{"rendered":"https:\/\/www.serenepharma.com\/?p=6364"},"modified":"2022-10-28T15:20:58","modified_gmt":"2022-10-28T10:20:58","slug":"qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi","status":"publish","type":"post","link":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/","title":{"rendered":"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">Havola: Kun DerLin va boshqalar, Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi, <em>Journal of Diabetes and Its Complications<\/em> (JDC), Murojaat sanasi: 2022 yil 12 yul, 108264, https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108264<\/p>\n\n\n\n<h3 class=\"wp-block-heading\"><strong>Maqsad<\/strong> <\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Qandli diabetning 2-turi bilan og&#8217;rigan bemorlarda vegetativ asab tizimining (VAT-VNS) disfunksiyasi kuzatilgan va depressiv yoki tashvish belgilari bilan birga keladigan kasalliklar glikemik nazoratning yomonligi bilan bog&#8217;liq. VNS indeksi sifatida elektrokardiogrammadan (EKG) aylantirilgan yurak ritmining o&#8217;zgaruvchanligi (VSR) dan foydalanilgan. Tadqiqotning maqsadi qandli diabetning 2-turi bilan og&#8217;rigan bemorlarda depressiya, tashvish, VSR va glikemik nazorat o&#8217;rtasidagi bog&#8217;liqlikni o&#8217;rganish edi.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>Asosiy ma`lumotlar<\/strong><\/p>\n\n\n\n<ul class=\"wp-block-list\"><li>Depressiya va glikatlangan gemoglobin (HbA1c) darajalari o&#8217;rtasida ijobiy &nbsp;bog`liqlik kuzatilgan.<\/li><li>Depressiya parasimpatik faollashuv (InHF) va HbA1c o&#8217;rtasida vositachilik qiladi.<\/li><li>Simpatik faollashuv, parasimpatik faollashuv va depressiya HbA1c darajasini bashorat qilishga imkon berdi.<\/li><\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Usullar<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">9-sonli bemor salomatligi so&#8217;rovnomasi&nbsp; (PHQ-9) va 7-sonli umumiy tashvish buzilishi so&#8217;rovi (GAD-7) qandli diabetning 2-turiga chalingan 647 bemorda (o&#8217;rtacha yoshi 63 \u00b1 10 yil, 56% erkaklar) depressiv va tashvish belgilarini baholash uchun qo`llanailgan. EKG dastlabri signallari o&#8217;tirish va dam olish holatida 5 daqiqali boshlang&#8217;ich chiziqda olingan, keyin VNS faollashuvi bilan bog&#8217;liq VSR o&#8217;lchovlariga aylantirilgan. Qondagi glyukoza va lipid darajalari, shu jumladan glikatlangan gemoglobin (HbA1c), yuqori zichlikdagi lipoproteinlar (LPVP), past zichlikdagi lipoprotein (LPNP) va triglitseridlar elektron tibbiy yozuvlaridan olingan.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Natijalar<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Ishtirokchilarning 99 nafarida (15%) depressiya alomatlari, 59 nafarida (9%) tashvish alomatlari bor edi. Depressiya va HbA1c darajasi parasimpatik faollashuv bilan salbiy bog&#8217;liq edi. Depressiya va tashvish simpatik asab tizimining faollashuvi bilan ijobiy bog&#8217;liq edi. Demografik ma`lumotlar va lipid profilini o&#8217;zgartirgandan so&#8217;ng, depressiya HbA1c darajasining muhim ijobiy prognozchisi bo`ldi; va VSR indekslari (InLF va InHF) HbA1c darajasining muhim salbiy prognozi faktorlari edi. Vositachilik ta&#8217;sirini tahlil qilish shuni ko&#8217;rsatdiki, depressiya parasimpatik faollashuv va glikemik nazorat o&#8217;rtasidagi vositachidir.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Xulosa<\/h3>\n\n\n\n<p class=\"wp-block-paragraph\">Pastroq parasimpatik faollashuv va ruhiy tushkunlikning yanada og&#8217;ir belgilari qandli diabetning 2-turi bilan og&#8217;rigan bemorlarda glikemik nazoratga ta&#8217;sir qilishi mumkin. Parasimpatik faollikni oshirish va depressiyani kamaytirishga qaratilgan terapiya dasturlari potentsial klinik foydalanish uchun glikemik natijalarga ta&#8217;siri o`rganish uchun qo&#8217;shimcha sinovdan o&#8217;tkazilishi mumkin.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Havola: Kun DerLin va boshqalar, Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi, Journal of Diabetes and Its Complications (JDC), Murojaat sanasi: 2022 yil 12 yul, 108264, https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108264 Maqsad Qandli diabetning 2-turi bilan og&#8217;rigan bemorlarda vegetativ asab tizimining (VAT-VNS) disfunksiyasi kuzatilgan va depressiv yoki tashvish belgilari bilan birga keladigan kasalliklar glikemik&#8230;<\/p>\n","protected":false},"author":1,"featured_media":6020,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"rs_blank_template":"","rs_page_bg_color":"","slide_template_v7":"","inline_featured_image":false,"footnotes":""},"categories":[141],"tags":[176],"class_list":["post-6364","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-gazetauz","tag-endokrinologiya"],"acf":[],"aioseo_notices":[],"aioseo_head":"\n\t\t<!-- All in One SEO 5.0.0.1 - aioseo.com -->\n\t<meta name=\"description\" content=\"Havola: Kun DerLin va boshqalar, Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi, Journal of Diabetes and Its Complications (JDC), Murojaat sanasi: 2022 yil 12 yul, 108264, https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108264 Maqsad Qandli diabetning 2-turi bilan og&#039;rigan bemorlarda vegetativ asab tizimining (VAT-VNS) disfunksiyasi kuzatilgan va depressiv yoki tashvish belgilari bilan birga keladigan kasalliklar glikemik\" \/>\n\t<meta name=\"robots\" content=\"max-image-preview:large\" \/>\n\t<meta name=\"author\" content=\"serene_admin\"\/>\n\t<meta name=\"google-site-verification\" content=\"E4w7Tq5OUsX4iPrZpEh5w3x9S4TTbvbUSzx6c5DiiDY\" \/>\n\t<meta name=\"yandex-verification\" content=\"4d7ed8a4cfca7240\" \/>\n\t<link rel=\"canonical\" href=\"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/\" \/>\n\t<meta name=\"generator\" content=\"All in One SEO (AIOSEO) 5.0.0.1\" \/>\n\t\t<meta property=\"og:locale\" content=\"uz_UZ\" \/>\n\t\t<meta property=\"og:site_name\" content=\"Serene - The Leading Pharmaceutical Company in Central Asia\" \/>\n\t\t<meta property=\"og:type\" content=\"article\" \/>\n\t\t<meta property=\"og:title\" content=\"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi - Serene\" \/>\n\t\t<meta property=\"og:description\" content=\"Havola: Kun DerLin va boshqalar, Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi, Journal of Diabetes and Its Complications (JDC), Murojaat sanasi: 2022 yil 12 yul, 108264, https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108264 Maqsad Qandli diabetning 2-turi bilan og&#039;rigan bemorlarda vegetativ asab tizimining (VAT-VNS) disfunksiyasi kuzatilgan va depressiv yoki tashvish belgilari bilan birga keladigan kasalliklar glikemik\" \/>\n\t\t<meta property=\"og:url\" content=\"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/\" \/>\n\t\t<meta property=\"og:image\" content=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png\" \/>\n\t\t<meta property=\"og:image:secure_url\" content=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png\" \/>\n\t\t<meta property=\"og:image:width\" content=\"83\" \/>\n\t\t<meta property=\"og:image:height\" content=\"80\" \/>\n\t\t<meta property=\"article:published_time\" content=\"2022-09-01T10:03:00+00:00\" \/>\n\t\t<meta property=\"article:modified_time\" content=\"2022-10-28T10:20:58+00:00\" \/>\n\t\t<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/Serenepharma\/\" \/>\n\t\t<meta name=\"twitter:card\" content=\"summary\" \/>\n\t\t<meta name=\"twitter:title\" content=\"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi - Serene\" \/>\n\t\t<meta name=\"twitter:description\" content=\"Havola: Kun DerLin va boshqalar, Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi, Journal of Diabetes and Its Complications (JDC), Murojaat sanasi: 2022 yil 12 yul, 108264, https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108264 Maqsad Qandli diabetning 2-turi bilan og&#039;rigan bemorlarda vegetativ asab tizimining (VAT-VNS) disfunksiyasi kuzatilgan va depressiv yoki tashvish belgilari bilan birga keladigan kasalliklar glikemik\" \/>\n\t\t<meta name=\"twitter:image\" content=\"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png\" \/>\n\t\t<script type=\"application\/ld+json\" class=\"aioseo-schema\">\n\t\t\t{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"BlogPosting\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\\\/#blogposting\",\"name\":\"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi - Serene\",\"headline\":\"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi\",\"author\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\"},\"publisher\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#organization\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/vysokiy_sahar_1-scaled.jpg\",\"width\":1500,\"height\":1000},\"datePublished\":\"2022-09-01T15:03:00+05:00\",\"dateModified\":\"2022-10-28T15:20:58+05:00\",\"inLanguage\":\"uz-UZ\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\\\/#webpage\"},\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\\\/#webpage\"},\"articleSection\":\"Gazeta, Endokrinologiya, Optional\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\\\/#breadcrumblist\",\"itemListElement\":[{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#listItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/#listItem\",\"name\":\"Gazeta\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/#listItem\",\"position\":2,\"name\":\"Gazeta\",\"item\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/\",\"nextItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\\\/#listItem\",\"name\":\"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi\"},\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#listItem\",\"name\":\"Home\"}},{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\\\/#listItem\",\"position\":3,\"name\":\"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi\",\"previousItem\":{\"@type\":\"ListItem\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/category\\\/gazetauz\\\/#listItem\",\"name\":\"Gazeta\"}}]},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#organization\",\"name\":\"Serene\",\"description\":\"The Leading Pharmaceutical Company in Central Asia\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/\",\"telephone\":\"+998782910140\",\"logo\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/wp-content\\\/uploads\\\/2022\\\/02\\\/logo-.png\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\\\/#organizationLogo\",\"width\":286,\"height\":120},\"image\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\\\/#organizationLogo\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/Serenepharma\\\/\",\"https:\\\/\\\/www.instagram.com\\\/serene_group_\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/\",\"name\":\"serene_admin\",\"image\":{\"@type\":\"ImageObject\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\\\/#authorImage\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/64ce6ede9180be17e1a7dac397b0fac976d02c34990350fde5853b7af19b7c70?s=96&d=mm&r=g\",\"width\":96,\"height\":96,\"caption\":\"serene_admin\"}},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\\\/#webpage\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\\\/\",\"name\":\"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi - Serene\",\"description\":\"Havola: Kun DerLin va boshqalar, Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi, Journal of Diabetes and Its Complications (JDC), Murojaat sanasi: 2022 yil 12 yul, 108264, https:\\\/\\\/doi.org\\\/10.1016\\\/j.jdiacomp.2022.108264 Maqsad Qandli diabetning 2-turi bilan og'rigan bemorlarda vegetativ asab tizimining (VAT-VNS) disfunksiyasi kuzatilgan va depressiv yoki tashvish belgilari bilan birga keladigan kasalliklar glikemik\",\"inLanguage\":\"uz-UZ\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#website\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\\\/#breadcrumblist\"},\"author\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\"},\"creator\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/author\\\/serene_admin\\\/#author\"},\"image\":{\"@type\":\"ImageObject\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/wp-content\\\/uploads\\\/2022\\\/10\\\/vysokiy_sahar_1-scaled.jpg\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\\\/#mainImage\",\"width\":1500,\"height\":1000},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/gazetauz\\\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\\\/#mainImage\"},\"datePublished\":\"2022-09-01T15:03:00+05:00\",\"dateModified\":\"2022-10-28T15:20:58+05:00\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#website\",\"url\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/\",\"name\":\"Serene\",\"description\":\"The Leading Pharmaceutical Company in Central Asia\",\"inLanguage\":\"uz-UZ\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.serenepharma.com\\\/uz\\\/#organization\"}}]}\n\t\t<\/script>\n\t\t<!-- All in One SEO -->\n\n","aioseo_head_json":{"title":"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi - Serene","description":"Havola: Kun DerLin va boshqalar, Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi, Journal of Diabetes and Its Complications (JDC), Murojaat sanasi: 2022 yil 12 yul, 108264, https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108264 Maqsad Qandli diabetning 2-turi bilan og'rigan bemorlarda vegetativ asab tizimining (VAT-VNS) disfunksiyasi kuzatilgan va depressiv yoki tashvish belgilari bilan birga keladigan kasalliklar glikemik","canonical_url":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/","robots":"max-image-preview:large","keywords":"","webmasterTools":{"google-site-verification":"E4w7Tq5OUsX4iPrZpEh5w3x9S4TTbvbUSzx6c5DiiDY","yandex-verification":"4d7ed8a4cfca7240","miscellaneous":""},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"BlogPosting","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/#blogposting","name":"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi - Serene","headline":"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi","author":{"@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author"},"publisher":{"@id":"https:\/\/www.serenepharma.com\/uz\/#organization"},"image":{"@type":"ImageObject","url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/10\/vysokiy_sahar_1-scaled.jpg","width":1500,"height":1000},"datePublished":"2022-09-01T15:03:00+05:00","dateModified":"2022-10-28T15:20:58+05:00","inLanguage":"uz-UZ","mainEntityOfPage":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/#webpage"},"isPartOf":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/#webpage"},"articleSection":"Gazeta, Endokrinologiya, Optional"},{"@type":"BreadcrumbList","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/#breadcrumblist","itemListElement":[{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/#listItem","position":1,"name":"Home","item":"https:\/\/www.serenepharma.com\/uz\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/#listItem","name":"Gazeta"}},{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/#listItem","position":2,"name":"Gazeta","item":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/","nextItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/#listItem","name":"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi"},"previousItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/#listItem","name":"Home"}},{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/#listItem","position":3,"name":"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi","previousItem":{"@type":"ListItem","@id":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/#listItem","name":"Gazeta"}}]},{"@type":"Organization","@id":"https:\/\/www.serenepharma.com\/uz\/#organization","name":"Serene","description":"The Leading Pharmaceutical Company in Central Asia","url":"https:\/\/www.serenepharma.com\/uz\/","telephone":"+998782910140","logo":{"@type":"ImageObject","url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/logo-.png","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/#organizationLogo","width":286,"height":120},"image":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/#organizationLogo"},"sameAs":["https:\/\/www.facebook.com\/Serenepharma\/","https:\/\/www.instagram.com\/serene_group_\/"]},{"@type":"Person","@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author","url":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/","name":"serene_admin","image":{"@type":"ImageObject","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/#authorImage","url":"https:\/\/secure.gravatar.com\/avatar\/64ce6ede9180be17e1a7dac397b0fac976d02c34990350fde5853b7af19b7c70?s=96&d=mm&r=g","width":96,"height":96,"caption":"serene_admin"}},{"@type":"WebPage","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/#webpage","url":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/","name":"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi - Serene","description":"Havola: Kun DerLin va boshqalar, Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi, Journal of Diabetes and Its Complications (JDC), Murojaat sanasi: 2022 yil 12 yul, 108264, https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108264 Maqsad Qandli diabetning 2-turi bilan og'rigan bemorlarda vegetativ asab tizimining (VAT-VNS) disfunksiyasi kuzatilgan va depressiv yoki tashvish belgilari bilan birga keladigan kasalliklar glikemik","inLanguage":"uz-UZ","isPartOf":{"@id":"https:\/\/www.serenepharma.com\/uz\/#website"},"breadcrumb":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/#breadcrumblist"},"author":{"@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author"},"creator":{"@id":"https:\/\/www.serenepharma.com\/uz\/author\/serene_admin\/#author"},"image":{"@type":"ImageObject","url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/10\/vysokiy_sahar_1-scaled.jpg","@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/#mainImage","width":1500,"height":1000},"primaryImageOfPage":{"@id":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/#mainImage"},"datePublished":"2022-09-01T15:03:00+05:00","dateModified":"2022-10-28T15:20:58+05:00"},{"@type":"WebSite","@id":"https:\/\/www.serenepharma.com\/uz\/#website","url":"https:\/\/www.serenepharma.com\/uz\/","name":"Serene","description":"The Leading Pharmaceutical Company in Central Asia","inLanguage":"uz-UZ","publisher":{"@id":"https:\/\/www.serenepharma.com\/uz\/#organization"}}]},"og:locale":"uz_UZ","og:site_name":"Serene - The Leading Pharmaceutical Company in Central Asia","og:type":"article","og:title":"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi - Serene","og:description":"Havola: Kun DerLin va boshqalar, Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi, Journal of Diabetes and Its Complications (JDC), Murojaat sanasi: 2022 yil 12 yul, 108264, https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108264 Maqsad Qandli diabetning 2-turi bilan og'rigan bemorlarda vegetativ asab tizimining (VAT-VNS) disfunksiyasi kuzatilgan va depressiv yoki tashvish belgilari bilan birga keladigan kasalliklar glikemik","og:url":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/","og:image":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png","og:image:secure_url":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png","og:image:width":83,"og:image:height":80,"article:published_time":"2022-09-01T10:03:00+00:00","article:modified_time":"2022-10-28T10:20:58+00:00","article:publisher":"https:\/\/www.facebook.com\/Serenepharma\/","twitter:card":"summary","twitter:title":"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi - Serene","twitter:description":"Havola: Kun DerLin va boshqalar, Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi, Journal of Diabetes and Its Complications (JDC), Murojaat sanasi: 2022 yil 12 yul, 108264, https:\/\/doi.org\/10.1016\/j.jdiacomp.2022.108264 Maqsad Qandli diabetning 2-turi bilan og'rigan bemorlarda vegetativ asab tizimining (VAT-VNS) disfunksiyasi kuzatilgan va depressiv yoki tashvish belgilari bilan birga keladigan kasalliklar glikemik","twitter:image":"https:\/\/www.serenepharma.com\/wp-content\/uploads\/2022\/02\/serene_logo_sticky.png"},"aioseo_meta_data":{"post_id":"6364","title":null,"description":null,"keywords":null,"keyphrases":null,"primary_term":null,"canonical_url":null,"og_title":null,"og_description":null,"og_object_type":"default","og_image_type":"default","og_image_url":null,"og_image_width":null,"og_image_height":null,"og_image_custom_url":null,"og_image_custom_fields":null,"og_video":null,"og_custom_url":null,"og_article_section":null,"og_article_tags":null,"twitter_use_og":false,"twitter_card":"default","twitter_image_type":"default","twitter_image_url":null,"twitter_image_custom_url":null,"twitter_image_custom_fields":null,"twitter_title":null,"twitter_description":null,"schema":{"blockGraphs":[],"customGraphs":[],"default":{"data":{"Article":[],"Course":[],"Dataset":[],"FAQPage":[],"Movie":[],"Person":[],"Product":[],"ProductReview":[],"Car":[],"Recipe":[],"Service":[],"SoftwareApplication":[],"WebPage":[]},"graphName":"","isEnabled":true},"graphs":[]},"schema_type":"default","schema_type_options":null,"pillar_content":false,"robots_default":true,"robots_noindex":false,"robots_noarchive":false,"robots_nosnippet":false,"robots_nofollow":false,"robots_noimageindex":false,"robots_noodp":false,"robots_notranslate":false,"robots_max_snippet":null,"robots_max_videopreview":null,"robots_max_imagepreview":"large","priority":null,"frequency":null,"local_seo":null,"breadcrumb_settings":null,"limit_modified_date":false,"ai":null,"created":"2026-02-11 16:31:41","updated":"2026-02-11 16:31:41","seo_analyzer_scan_date":null,"focus_keyword":null,"additional_keywords":null,"truseo_locale":null},"aioseo_breadcrumb":"<div class=\"aioseo-breadcrumbs\"><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.serenepharma.com\/uz\/\" title=\"Home\">Home<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\t<a href=\"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/\" title=\"Gazeta\">Gazeta<\/a>\n\t\t<\/span><span class=\"aioseo-breadcrumb-separator\">\u00bb<\/span><span class=\"aioseo-breadcrumb\">\n\t\t\tQandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi\n\t\t<\/span><\/div>","aioseo_breadcrumb_json":[{"label":"Home","link":"https:\/\/www.serenepharma.com\/uz\/"},{"label":"Gazeta","link":"https:\/\/www.serenepharma.com\/uz\/category\/gazetauz\/"},{"label":"Qandli diabetning 2-turida (QD2) glikemik nazorat bilan depressiya va parasimpatik faollashuvning bog`liqligi","link":"https:\/\/www.serenepharma.com\/uz\/gazetauz\/qandli-diabetning-2-turida-qd2-glikemik-nazorat-bilan-depressiya-va-parasimpatik-faollashuvning-bogliqligi\/"}],"_links":{"self":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/posts\/6364","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/comments?post=6364"}],"version-history":[{"count":0,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/posts\/6364\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/media\/6020"}],"wp:attachment":[{"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/media?parent=6364"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/categories?post=6364"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.serenepharma.com\/uz\/wp-json\/wp\/v2\/tags?post=6364"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}